Shyeilla V Dhuria

Title: Shyeilla V Dhuria: Innovator in Pharmaceutical Compositions

Introduction

Shyeilla V Dhuria is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in enhancing the targeting of therapeutic compounds to the central nervous system (CNS). With a total of two patents to his name, Dhuria's work is paving the way for advancements in drug delivery systems.

Latest Patents

Dhuria's latest patents focus on pharmaceutical compositions and methods for enhancing the targeting of therapeutic compounds to the CNS. These innovations involve intranasal administration techniques that aim to reduce non-target exposure. In certain embodiments, at least one vasoconstrictor is administered intranasally prior to the therapeutic compound. Other embodiments combine the vasoconstrictor(s) and therapeutic compound(s) in a single pharmaceutical composition for intranasal delivery. This invention significantly improves the targeting of therapeutic compounds to the CNS while minimizing unwanted systemic exposure. The preferred method of administration applies the vasoconstrictor(s) and/or therapeutic compound(s) to the upper third of the nasal cavity, although application to the lower two-thirds is also included in the scope of the invention.

Career Highlights

Throughout his career, Shyeilla V Dhuria has worked with reputable organizations such as HealthPartners Institute and HealthPartners Research Foundation. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Dhuria has collaborated with notable colleagues, including William Howard Frey, II and Leah Ranae Bresin Hanson. These partnerships have further enriched his research endeavors and innovations in the pharmaceutical field.

Conclusion

Shyeilla V Dhuria is a distinguished inventor whose work in pharmaceutical compositions is making a significant impact on drug delivery systems. His innovative approaches are set to enhance therapeutic targeting and improve patient outcomes.